Hip Replacement News and Research

RSS

New anterior approach in hip-replacement surgery results in less pain, faster recovery

The morning after undergoing a total hip replacement, Sean Toohey walked up half a flight of stairs at the hospital. That afternoon, he progressed from a walker to crutches to a cane. And 15 days after his surgery, he returned to work, no longer hobbled by a severely arthritic hip that had been bone-on-bone.

6 Nov 2012

FDA expands Janssen’s Xarelto use to reduce risk of DVT and PE

The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following initial treatment.

3 Nov 2012

Isis commences ISIS-FXIRx Phase 2 study in knee replacement surgery patients

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 comparator-controlled study evaluating ISIS-FXIRx in patients undergoing knee replacement surgery, also referred to as total knee arthroplasty (TKA).

29 Oct 2012

Age, gender influence hip arthroplasty revision risk

Patient age and gender have a significant effect on the risk for revisions after primary total hip replacement, show study findings.

26 Oct 2012

Obese patients more likely to have complications after total knee replacement surgery

Obese patients have a greater risk of complications following total knee replacement surgery, including post-surgical infections, according to a new literature review recently published in the Journal of Bone and Joint Surgery (JBJS).

25 Oct 2012

Study identifies pitfalls in current calculation of hospital readmission rates in spine surgery

When hospital patients have to be readmitted soon after discharge, hospitals look bad. And in addition to reflecting poorly on a hospital's quality of care, a high readmission rate also can result in reduced Medicare reimbursements, under provisions now taking effect under the 2010 health care law.

12 Oct 2012

Hip resurfacing unsuitable for women

Metal-on-metal resurfacing for osteoarthritis should be used only in men with a large femoral head, UK researchers believe.

5 Oct 2012

Hip resurfacing prone to early failure

Hip resurfacing – an alternative to hip replacement often recommended to younger patients – is prone to early failure in many instances, and should not be used in women, according to an Article published Online First in The Lancet.

2 Oct 2012

Hip implants are more likely to fail in obese people due to thigh size

University of Iowa researchers have determined that thigh size in obese people is a reason their hip implants are more likely to fail.

20 Sep 2012

Apixaban offers minor added benefit for adult patients after hip replacement

The clot-inhibiting drug apixaban was approved in May 2011 for the prevention of thrombosis (blood clots) after operations to replace a hip or knee joint.

18 Sep 2012

Rhode Island receives NIH grant to study cartilage and joint health

Rhode Island Hospital's Center of Biomedical Research Excellence (COBRE) in Skeletal Health and Repair has been awarded a $10.8 million grant from the National Institutes of Health (NIH), one of the largest grants in Rhode Island Hospital history. This grant, to be paid over five years, will fund studies of cartilage and joint health.

11 Sep 2012

Some smaller clots may not require potentially risky treatment

Men and women who undergo joint replacement procedures, as well as those who have significant fractures, tend to be at an increased risk of developing pulmonary emboli (PE), blood clots that travel to the lungs where they may cause serious complications and even death.

1 Sep 2012

Increased risk for AMI following hip- and knee-replacement surgery

Elderly patients are at a significantly increased risk for acute myocardial infarction in the 2 weeks following total hip- or knee-replacement surgery, research shows.

27 Jul 2012

U.S. News & World Report names Hospital for Special Surgery among 2012 America's Best Hospitals

For the third consecutive year, U.S. News & World Report named Hospital for Special Surgery the top hospital in the country for orthopedics in its 2012 "America's Best Hospitals" survey. Once again, the hospital ranked as a leader in rheumatology at number three in the nation. In addition, neurology was ranked at No. 10.

17 Jul 2012

NHS hospitals have scope to make efficiency savings by adopting best practice

NHS hospitals have substantial scope to improve their efficiency by adopting best practice, according to research published today by Professor Andrew Street and colleagues at the Centre for Health Economics (CHE) at the University of York.

14 Jul 2012

JRD receives FDA priority review designation for XARELTO sNDAs to treat PE, DVT

Janssen Research & Development, LLC (Janssen R&D) announced today the U.S. Food and Drug Administration (FDA) has assigned a priority review designation to the supplemental New Drug Applications (sNDAs) filed on May 2, 2012 for XARELTO (rivaroxaban), an oral anticoagulant, seeking new indications to treat patients with deep vein thrombosis (DVT), pulmonary embolism (PE), and to prevent recurrent DVT and PE.

9 Jul 2012

Birmingham hip resurfacing offers lowest mortality risk

Men with osteoarthritis who undergo Birmingham hip resurfacing have a lower risk for mortality than patients undergoing cemented or uncemented total hip arthroplasty, UK researchers reveal.

25 Jun 2012

Staff at Sheffield Teaching Hospitals shortlisted for more awards than any other trust in the country

Teams of staff at Sheffield Teaching Hospitals have been recognised for their hard work by gaining more shortlisted entries in two high profile national award schemes than any other trust in the country.

25 Jun 2012

Janssen receives FDA complete response letter for XARELTO sNDA

Janssen Research & Development, LLC (Janssen R&D) announced today the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding a supplemental New Drug Application (sNDA) for XARELTO (rivaroxaban) for the reduction of the risk of secondary cardiovascular events in patients with acute coronary syndrome (ACS).

22 Jun 2012

Laparoscopic sleeve gastrectomy safer than bariatric and metabolic surgery

Studies from Stanford University, Cleveland Clinic Florida and the Naval Medical Center in San Diego show laparoscopic sleeve gastrectomy, an increasingly popular surgical procedure where the stomach is reduced by 85 percent, is as safe as or safer than laparoscopic gastric bypass or gastric banding. The studies* were presented here at the 29th Annual Meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS).

21 Jun 2012